| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Protalix BioTherapeutics, Inc. | Director | Common Stock | 7,500 | $16,950 | $2.26 | 18 Nov 2025 | By Trust |
| Protalix BioTherapeutics, Inc. | Director | Common Stock | 0 | $0 | $1.87 | 18 Nov 2025 | Direct |
| Protalix BioTherapeutics, Inc. | Director | Stock Options (Right to Buy) | 15,000 | 03 Sep 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| PLX | Protalix BioTherapeutics, Inc. | 18 Nov 2025 | 1 | -$314 | 4 | Director | 19 Nov 2025, 16:34 |
| PLX | Protalix BioTherapeutics, Inc. | 03 Sep 2025 | 2 | $0 | 4 | Director | 04 Sep 2025, 17:00 |
| PLX | Protalix BioTherapeutics, Inc. | 29 Sep 2023 | 1 | $0 | 4 | Director | 03 Oct 2023, 17:00 |
| PLX | Protalix BioTherapeutics, Inc. | 07 Sep 2022 | 1 | $0 | 4 | Director | 09 Sep 2022, 17:01 |